This content is from: Innovation

CME To Stay Focused On OTC

Craig Donohue, ceo of CME Group, said his firm will continue to focus on “doing what we do well,” namely in futures and over-the-counter derivatives, reports Bloomberg.

Craig Donohue, ceo of CME Group, said his firm will continue to focus on “doing what we do well,” namely in futures and over-the-counter derivatives. Donohue made his comments in an interview, without commenting whether CME would make a bid for either Deutsche Boerse or NYSE Euronext, which recently announced a merger deal.

Click here to read the story from Bloomberg

Related Content